ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 787 • 2017 ACR/ARHP Annual Meeting

    Prevalence of Relapses of Giant Cell Arteritis in Patients Treated with Corticosteroids: A Meta-Analysis

    Alexandra Addario1, Quitterie Reynaud2,3, Maxime Samson4, Mathilde Francois3, Stéphane Durupt3, Francois Gueyffier1, Michel Cucherat1, Isabelle Durieu2,5 and Jean-Christophe Lega3,6, 1Equipe Evaluation et Modélisation des Effets thérapeutiques, Lyon 1 University, Lyon, France, 2HESPER group, Lyon 1 University, Lyon, France, 3Department of Internal and Vascular Medicine, Lyon Sud Hospital, Hospices Civils de Lyon, Lyon, France, 4Department of Internal Medicine and Clinical Immunolgy, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 5Department of Internal and Vascular, Lyon Sud Hospital, Hospices Civils de Lyon, Lyon, France, 6Equipe Evaluation et Modélisation des Effets thérapeutiques, UMR CNR 5558, Lyon 1 University, Lyon, France

    Background/Purpose:  The relapse rate of giant cell arteritis (GCA) in the patients treated by corticosteroids (CS) varied widely in observational series and randomized trials. The…
  • Abstract Number: 788 • 2017 ACR/ARHP Annual Meeting

    Mast Cell Mediated Inhibition of Systemic IL-6 in candida Albicans Water-Soluble Fraction (CAWS) Induced Model of Large Vessel Vasculitis

    Mingcai Zhang1, Mehrdad Maz2, Don Smith3, Noriko Miura4, Naohito Ohno5, Kottarappat Dileepan6 and Jason Springer7, 1Department of Orthopedics, University of Kansas Medical Center, Kansas City, KS, 2Allergy, Clinical Immunology, and Rheumatology, Division of Allergy, Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, 3University of Kansas Medical Center, Kansas City, KS, 4School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan, 5Tokyo University of Pharmacy and Lift Sciences, Tokyo, Japan, 6Department of Medicine, University of Kansas Medical Center, Kansas, KS, 7Department of Internal Medicine, Division of Allergy, Clinical Immunology, & Rheumatology, Kansas University Medical Center, Kansas City, KS

    Background/Purpose: In forms of large vessel vasculitis (LVV) systemic IL-6 has been shown to follow disease activity. Furthermore, IL-6 inhibition is an effective treatment for…
  • Abstract Number: 789 • 2017 ACR/ARHP Annual Meeting

    Markers of Inflammation and Patient-Reported Measures As Predictors of Relapse in Giant Cell Arteritis

    Tanaz A. Kermani1, Antoine G. Sreih2, Gunnar Tomasson3, David Cuthbertson4, Renee Borchin5, Simon Carette6, Lindsy J. Forbess7, Nader A. Khalidi8, Curry L. Koening9, Carol A. McAlear10, Paul A. Monach11, Larry W. Moreland12, Christian Pagnoux6, Philip Seo13, Robert F. Spiera14, Kenneth J. Warrington15, Steven R. Ytterberg15, Carol A. Langford16 and Peter A. Merkel17,18, 1Rheumatology, University of California Los Angeles, Los Angeles, CA, 2Rheumatology, University of Pennsylvania, Philadelphia, PA, 3University of Iceland, Faculty of Medicine, Reykjavik, IS, 4Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, 5University of South Florida, Tampa, FL, 6Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 7Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 8Rheumatology, McMaster University, Hamilton, ON, Canada, 9Rheumatology, University of Utah, Salt Lake City, UT, 10University of Pennsylvania, Philadelphia, PA, 11Boston University School of Medicine, Boston, MA, 12Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 13Medicine, Johns Hopkins University, Baltimore, MD, 14Rheumatology, Hospital for Special Surgery, New York, NY, 15Rheumatology, Mayo Clinic, Rochester, MN, 16Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 17Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 18Biostatistics, Epidemiology, and Bioinformatics, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The significance of increasing erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in clinically asymptomatic individuals with giant cell arteritis (GCA) is controversial. Patient-reported…
  • Abstract Number: 790 • 2017 ACR/ARHP Annual Meeting

    Pre-Clinical Evidences of Immunomodulatory Activities of Tuftsin-Phosphorylcholine on Samples from Patients with Giant Cell Arteritis in Comparison to Corticosteroids

    Stefania Croci1, Martina Bonacini1, Francesco Muratore2,3, Andrea Caruso3, Antonio Fontana4, Luigi Boiardi3, Alessandra Soriano3,5, Alberto Cavazza6, Luca Cimino7, Lucia Belloni1, Maria Parmeggiani1, Miri Blank8,9, Yehuda Shoenfeld8,9 and Carlo Salvarani2,3, 1Unit of Clinical Immunology, Allergy and Advanced Biotechnologies, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, Reggio Emilia, Italy, 2University of Modena and Reggio Emilia, Italy, Modena, Italy, 3Unit of Rheumatology, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, Reggio Emilia, Italy, 4Unit of Vascular Surgery, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, Reggio Emilia, Italy, 5Campus Bio-Medico, University of Rome, Italy, Roma, Italy, 6Unit of Pathology, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, Reggio Emilia, Italy, 7Unit of Ocular Immunology, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, Reggio Emilia, Italy, 8Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel, Ramat-Gan, Israel, 9Sackler Faculty of Medicine, Tel-Aviv University, Israel, Tel-Aviv, Israel

    Background/Purpose: Tuftsin-PhosphorylCholine (TPC) is a novel bi-specific molecule which has shown immunomodulatory effects in experimental mouse models of lupus, colitis and arthritis but data in…
  • Abstract Number: 791 • 2017 ACR/ARHP Annual Meeting

    Aortic Dilatation in Patients with Large Vessel Vasculitis: A Longitudinal Case Control Study Using Positron Emission Tomography/Computed Tomography

    Filippo Crescentini1, Francesco Muratore2, Lucia Spaggiari3, Giulia Pazzola1, Luigi Boiardi1, Nicolò Pipitone1 and Carlo Salvarani4, 1Rheumatology Unit, Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia, Italy, 2Rheumatology Unit, Arcispedale Santa Maria Nuova - IRCCS; Università di Modena e Reggio Emilia, Reggio Emilia, Italy, 3Radiology Unit, Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia, Italy, 4Rheumatology Unit, Arcispedale Santa Maria Nuova - IRCCS; Università di Modena e Reggio Emilia, Reggio-Emilia, Italy

    Background/Purpose: To evaluate aortic diameter and predictors of aortic dilatation using FDG-PET/CT in a longitudinally followed cohort of patients with large vessel vasculitis (LVV) compared…
  • Abstract Number: 792 • 2017 ACR/ARHP Annual Meeting

    Glucocorticoid Use and Adverse Events in Patients with Polymyalgia Rheumatica in a Contemporary Population-Based Cohort

    Izzat Shbeeb1, Divya Challa1, Shafay Raheel2, Cynthia S. Crowson3 and Eric L. Matteson4, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Rheumatology, Mayo Clinic, Rochester, MN, 3Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

    Background/Purpose: To investigate the use of glucocorticoids (GC) and related adverse events (AE) in a long-term, geographically-defined cohort of patients with polymyalgia rheumatica (PMR). Methods:…
  • Abstract Number: 793 • 2017 ACR/ARHP Annual Meeting

    Metotrexate in the Treatment of Giant Cell Arteritis: To be or Not to be

    Ignacio Castaño1, Irene Monjo2, Alejandro Balsa3, Diana Peiteado2, Sara García-Carazo4 and Eugenio De Miguel1, 1Medicine, Universidad Autonoma Madrid, MADRID, Spain, 2Rheumatology, Hospital Universitario La Paz, MADRID, Spain, 3Rheumatology, Hospital La Paz-IdiPAZ, Madrid, Spain, 4Rheumatology, La Paz University Hospital, Madrid, Spain

    Background/Purpose: The high-dose glucocorticoids (GCs) are the mainstay of treatment in Giant Cell Arteritis (GCA). Patients treated with greater GC dosages are at the greatest…
  • Abstract Number: 794 • 2017 ACR/ARHP Annual Meeting

    Negative Temporal Artery Biopsies: Comparison between Biopsy-Negative GCA and Non-GCA Patients

    Karthik Yeruva1, Kenneth J. Warrington1, Cynthia S. Crowson2 and Matthew J. Koster1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN

    Background/Purpose: Temporal artery biopsy (TAB) plays a key role in diagnosis of giant cell arteritis (GCA). However, approximately 15-20% of patients ultimately diagnosed with GCA…
  • Abstract Number: 795 • 2017 ACR/ARHP Annual Meeting

    Characteristics and Treatment Outcomes of Giant Cell Arteritis with Large-Vessel Lesions in a Nationwide, Retrospective Cohort Study in Japan

    Takahiko Sugihara1, Hitoshi Hasegawa2, Haruhito Uchida3, Hajime Yoshifuji4, Yoshikazu Nakaoka5, Yoshiko Watanabe6, Eisuke Amiya7, Masanori Konishi8, Yasuhiro Katsumata9, Yoshinori Komagata10, Taio Naniwa11,12, Takahiro Okazaki13, Yoshiya Tanaka14, Tsutomu Takeuchi15, Masayoshi Harigai16, Yoshihiro Arimura17 and Mitsuaki Isobe8,18, 1Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 2Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan, 3Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 4Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 5Osaka University Graduate School of Medicine, Osaka, Japan, 6First Department of Physiology, Kawasaki Medical School, Kurashiki, Japan, 7Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 8Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan, 9Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 10First Dept. of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan, 11Division of Rheumatology, Dept of Internal Medicine,, Nagoya City University Hospital, Nagoya, Japan, 12Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 13Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 14The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 15Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 16Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 17First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan, 18Sakakibara Heart Institute, Tokyo, Japan

    Background/Purpose: Giant cell arteritis (GCA) often affects aorta or its branches, but it is unclear whether the large-vessel (LV) lesions are associated with treatment outcomes.…
  • Abstract Number: 796 • 2017 ACR/ARHP Annual Meeting

    Presentation and Outcome of Large-Vessel Vasculitis Diagnosed between 50 and 60 Years: Case-Control Study Based on 183 Cases

    Laure Delaval1,2, Aurélie Daumas3, Maxime Samson4, Mikael Ebbo5, Hubert de Boysson6, Eric Liozon7, Henry Dupuy8, Alexis Regent9, Mathieu Puyade10, Daniel Blockmans11, Estibaliz Lazaro12, Ygal Benhamou13, Karim Sacre14, Alice Bérezné15, Loïc Guillevin2,9,16 and Benjamin Terrier17,18,19, 1National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, paris, France, 2Internal medicine, Cochin University Hospital, paris, France, 3Department of Internal Medicine, Aix-Marseille Université, La Timone University Hospital, AP-HM, Marseille, France, 4Department of Internal Medicine and Clinical Immunology, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 5internal medicine, Aix-Marseille Université, La Timone University Hospital, AP-HM, Paris, France, 6Department of Internal Medicine, Caen University Hospital, Caen, France, 7Departement of Internal Medicine, Limoges University Hospital, Limoges, France, 8Department of Internal Medicine, Haut-Lévêque Hospital, Pessac, France, 9National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 10Department of Internal Medicine, University Hospital of Poitiers, Poitiers, France, 11General Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium, 12Department of Internal Medecine and Clinical Immunology, Bordeaux University Hospital, Pessac, France, 13Department of internal medicine, University Hospital of Rouen, Rouen, France, 14Department of Internal Medicine, Bichat Hospital, Paris, France, 15Department of internal medicine, CHR Annecy-Genevois, Metz-Tessy, France, 16French Vasculitis Study Group (FVSG), Paris, France, 17Service de Médecine Interne, Hôpital Cochin, Centre de référence national pour les maladies systémiques autoimmunes rares d’Ile de France, DHU Authors, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, Paris, France, 18Internal Medicine, Cochin University Hospital, Paris, France, 19French Vasculitis Study Group (FVSG), paris, France

    Background/Purpose: Primary large-vessel vasculitis (LVV) include giant cell arteritis (GCA) and Takayasu arteritis (TA). Age at onset is commonly used to distinguish GCA and TA.…
  • Abstract Number: 797 • 2017 ACR/ARHP Annual Meeting

    Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A Retrospective Study of 50 Cases

    Laure Delaval1,2, Maxime Samson3, Flora Schein4, Christian Agard5, Olivier Aumaître6, Alban Deroux7, Henry Dupuy8, Cyril Garrouste9, cedric landron10, Francois Maurier11, Pascal Cathebras12, Loïc Guillevin2,13,14 and Benjamin Terrier15,16,17, 1National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, paris, France, 2Internal medicine, Cochin University Hospital, paris, France, 3Department of Internal Medicine and Clinical Immunology, Hôpital François Mitterrand, CHU de Dijon, Dijon, France, 4Internal medicine, University Hospital St Etienne, Saint Etienne, France, 5Internal Medicine Department, Nantes University Hospital, Nantes, France, 6CHU Pitié-Salpêtrière - Department of Internal Medicine 2. Referal center for SLE/APS, Paris, France, 7Internal Medicine, CHU de Grenoble, Grenoble, France, 8Department of Internal Medicine, Haut-Lévêque Hospital, Pessac, France, 9Nephrology, CHU, Clermont-Ferrand, France, 10service de médecine interne, CH Poitiers, CHU Poitiers, poitiers, France, 11Internal Medicine, Sainte-Blandine de Metz Hospital, Metz, France, 12Internal Medicine, University Hospital St Etienne, St Etienne, France, 13French Vasculitis Study Group (FVSG), Paris, France, 14National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 15Service de Médecine Interne, Hôpital Cochin, Centre de référence national pour les maladies systémiques autoimmunes rares d’Ile de France, DHU Authors, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France, Paris, France, 16French Vasculitis Study Group (FVSG), paris, France, 17Internal Medicine, Cochin University Hospital, Paris, France

    Background/Purpose: Giant cell arteritis (GCA) is a non-necrotizing granulomatous arteritis involving large vessels, whereas antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV) are a group of necrotizing…
  • Abstract Number: 798 • 2017 ACR/ARHP Annual Meeting

    Altered Phenotype of Platelets and Neutrophils Toward Neutrophil-Platelet Interaction in Circulation of Small and Large Vessel Vasuculitis

    Kotaro Matsumoto1, Hidekata Yasuoka2, Komei Sakata1, Keiko Yoshimoto1,3, Katsuya Suzuki1,4, Kunihiro Yamaoka1 and Tsutomu Takeuchi1, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 235 Shinanomachi, Shinjuku, Keio University School of Medicine, Tokyo, Japan, 3Keio University School of Medicine, Clinical and Translational Research Center, Tokyo, Japan, 4Division of Rheumatology, Department of Internal Medicine, Keio University School of Medcine, Tokyo, Japan

    Background/Purpose: Neutrophils play an important role in the pathogenesis of necrotizing vasculitis, and activation of neutrophil is one of important triggers of the disease process.…
  • Abstract Number: 799 • 2017 ACR/ARHP Annual Meeting

    Acetylcholinesterase Is Highly Expressed in the Inflamed Vessel Wall of Patients with Giant Cell Arteritis

    Philip Therkildsen1, Berit Dalsgaard Nielsen1, Kresten Krarup Keller2, Torben Steiniche3, Lars Christian Gormsen4, Ib Tønder Hansen5 and Ellen-Margrete Hauge6, 1Department of Rheumatology, Aarhus University Hospital, Aarhus C, Denmark, 2Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 3Department of Histopathology, Aarhus University Hospital, Aarhus C, Denmark, 4Nuclear Medicine and PET Center, Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Århus C, Denmark, 5Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 6Department of Rheumatology, Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: The temporal artery biopsy (TAB) remains the gold standard in the diagnosis of giant cell arteritis (GCA). However, TABs are false-negative in 40% of…
  • Abstract Number: 800 • 2017 ACR/ARHP Annual Meeting

    Measurement of Serum Cytokines during the Apparent Remission State of Takayasu Arteritis – What Do Cytokines Tell Us?

    Bruna Savioli1, Bruno Salu2, Marlon Vilela2, Maria Luiza Vilela Oliva2 and Alexandre W.S. Souza3,4, 1Internal Medicine - Rheumatology Division, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil, 2Biochemistry, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil, 3Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 4Internal Medicine, Universidade Federal de São Paulo, São Paulo, Brazil

    Background/Purpose: The definition of remission in Takayasu arteritis (TA) is a challenge in clinical practice, since smoldering arterial inflammation may occur without overt signs and…
  • Abstract Number: 801 • 2017 ACR/ARHP Annual Meeting

    PET-CT Findings and Clinical Outcomes in Takayasu Arteritis – Does 18F-Fluorodeoxyglucose Uptake in Arteries Predict Relapses?

    Anna Larissa Faria Janes1, Míriam Fang Castro1, Bruna Savioli1, Anne Elisabeth Diniz Arraes1, Emilia Sato2 and Alexandre W.S. Souza3, 1Internal Medicine - Rheumatology Division, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil, 2Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil

    Background/Purpose: PET-CT scan with 18F-Fluorodeoxyglucose (18F-FDG) has been frequently used as a tool to assess disease activity in Takayasu arteritis (TA) and increased 18F-FDG uptake…
  • « Previous Page
  • 1
  • …
  • 1256
  • 1257
  • 1258
  • 1259
  • 1260
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology